Effect of omalizumab on patients with chronic urticaria.
about
Profile of omalizumab in the treatment of chronic spontaneous urticariaManagement of difficult urticariaWhat'S new in urticaria?Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report.Urticaria and angioedema.Omalizumab therapy in three patients with chronic autoimmune urticaria.Omalizumab, an anti-immunoglobulin E antibody: state of the art.Anti-immunoglobulin e therapyDiagnosis and treatment of urticaria and angioedema: a worldwide perspective.New concepts in chronic urticaria.Allergy and the skin.Safety of omalizumab in asthma.What to do with refractory urticaria patients.Immune modulation for treatment of allergic disease.Pathogenic intracellular and autoimmune mechanisms in urticaria and angioedema.Biologic agents in the treatment of urticaria.Anti-IgE--emerging opportunities for Omalizumab.Treatment of refractory chronic urticaria: current and future therapeutic options.Update and insights into treatment options for chronic spontaneous urticaria.The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update.Treatment of severely recalcitrant chronic spontaneous urticaria: a discussion of relevant issues.Omalizumab for the treatment of chronic urticaria.Role of biologics in intractable urticaria.Therapy of antihistamine-resistant chronic spontaneous urticaria.Omalizumab for treating chronic spontaneous urticaria: an expert review on efficacy and safety.Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.Treatment of Chronic Spontaneous Urticaria with a Single Dose of Omalizumab: A Study of Four Cases.Eosinophils in chronic urticaria: supporting or leading actors?Severe asthma and the omalizumab option.The potential role of omalizumab in the treatment of chronic urticaria.Treatment of chronic spontaneous urticaria.Omalizumab for chronic urticaria: a case series and overview of the literatureT cell activity in successful treatment of chronic urticaria with omalizumab.Anti-IgE Treatment for Disorders Other Than Asthma.Chronic urticaria and treatment options.Down regulation of the high-affinity IgE receptor associated with successful treatment of chronic idiopathic urticaria with omalizumab.Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria.Efficacy of omalizumab in chronic spontaneous urticaria refractory to conventional therapy: analysis of 110 patients in real-life practice.Case reports in dermatology: loved by clinicians, loathed by editors, and occasionally important.Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: a real life survey.
P2860
Q26783158-04344F0E-C8A4-4850-8668-C18A405BC347Q33607673-E8299976-8981-4DC3-A0CA-805EA438047AQ33607678-F8B90C16-9141-441E-A7A4-1E5A02FAC168Q34150295-77F6A8C6-36C3-4689-8ED6-01A345805D95Q34215915-B7381BC5-0396-4F24-9B85-64C1070DD10EQ34363209-861A0ECE-F523-401C-9CC8-93A045C4ECD8Q35095218-59AC84F1-4F36-48E9-9EA9-57D8287965EEQ36834564-B8F72FEB-247D-451F-9FAC-4CDB7BB0F99BQ36834774-D6810C6E-C53D-4176-B9BA-74DFB9AB7B16Q37029360-030C0799-2D17-4C26-9D3C-4A8A5799A635Q37249808-74D2671E-C026-44B6-A4C8-630A809751C0Q37852717-A1D60DD7-8D5F-4261-824B-3418B79DFE30Q37856874-619B2468-DA6B-4224-8A99-1A4072D7DC1FQ37891140-01181CA9-F7BE-4B79-86FC-26104CFF4E78Q38016756-19FFAF3B-505A-4EDB-8AB5-F3B11437A83DQ38022183-A4CA30F7-6A06-4B28-87DA-0BC7A96EFE37Q38091754-07AFA931-5E69-4943-BA19-F36F74410D92Q38148494-6D372289-C63E-477E-B6EC-3F5F33A943D9Q38188032-5C2244AB-2218-46EE-B2A6-CAACAC8CCEC9Q38208428-02623547-D181-4959-8649-4A0912241A37Q38276193-C8AC139B-401D-4D43-880C-E89E9E559570Q38310407-43CFF9E6-4559-44C2-AECD-C82E9DE52C7FQ38450662-DF6F3C51-14E1-44FE-BB84-2187133827F1Q38981770-A2FE3348-8CB4-417A-A7A1-5DDCB06E9E44Q38997626-F4941AE3-9F5A-47B7-9FA8-4B41F7D534CEQ39012896-87F79951-1BFE-433F-974A-6A7109437FC2Q39168827-7D71D663-C82A-4BBF-A4DE-FBB1C2286271Q39806851-2CC23847-2279-475B-ABD8-89D52AF39040Q40740336-F3BDACD7-0A97-4DFB-889D-D036C0681CE0Q41755302-DA138086-5444-4255-AEAB-AD491F381520Q41786093-FB96D9DC-6191-4168-97DE-4CE524886192Q41991600-39175201-D5EB-452B-AFF8-75B215F94F87Q42065890-C3D94E5A-6806-4F67-9A09-61BB98DF77F2Q42091038-C8B21F41-3208-4D2B-9CF1-5C3F0E56FF4FQ42101784-5E5375A1-7AD6-4527-BCF3-20C5C21944C2Q42586085-7425ACE2-4DE7-44BE-B243-D87154C15F9DQ46196780-C32DEE36-1A00-426A-B449-9E125F8BAE07Q47960148-64625BB0-DA65-4826-97B6-9F0E86982017Q48352789-F1C06D26-FAE0-482A-B46C-22067DB18BCDQ48502465-D6D05F14-A36E-43C1-A6B3-7D3A4DB44A4D
P2860
Effect of omalizumab on patients with chronic urticaria.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Effect of omalizumab on patients with chronic urticaria.
@en
Effect of omalizumab on patients with chronic urticaria.
@nl
type
label
Effect of omalizumab on patients with chronic urticaria.
@en
Effect of omalizumab on patients with chronic urticaria.
@nl
prefLabel
Effect of omalizumab on patients with chronic urticaria.
@en
Effect of omalizumab on patients with chronic urticaria.
@nl
P1476
Effect of omalizumab on patients with chronic urticaria.
@en
P2093
Ricardo A Tan
Sheldon L Spector
P304
P356
10.1016/S1081-1206(10)60644-8
P577
2007-08-01T00:00:00Z